Home › Funds › SEIZERT CAPITAL PARTNERS, LLC › UTHR

SEIZERT CAPITAL PARTNERS, LLC position in UTHR

UNITED THERAPEUTICS CORP DEL · Health Care

SEIZERT CAPITAL PARTNERS, LLC reported holding 72,712 shares of UTHR (UNITED THERAPEUTICS CORP DEL) in its Q3 2026 13F filing — a position valued at US$39.4M, representing 1.71% of its reported portfolio and ranking #31 among its reported holdings. SEIZERT CAPITAL PARTNERS, LLC has disclosed UTHR holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)72.71K sh
Reported value held$39.40M
Portfolio Weight1.71%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How SEIZERT CAPITAL PARTNERS, LLC's UTHR position evolved

SEIZERT CAPITAL PARTNERS, LLC first disclosed a stake in UTHR in Q3 2023 at 29,158 shares (US$6.6M). The position peaked in Q4 2025 at 145,522 shares, worth US$70.9M. Across 13 filings, SEIZERT CAPITAL PARTNERS, LLC increased the stake 6 time(s), trimmed it 6 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 72,712 shares valued at US$39.4M — a reduction of -4,116 shares quarter over quarter.. Notable position changes include a 59% increase in Q3 2024 (shares fell 2% over the following quarter), a 203% increase in Q1 2025 (shares fell 8% over the following quarter), a 28% trim in Q1 2026 (shares fell 9% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 29.16K $6.59M New
Q4 2023 25.07K $5.51M Reduce
Q1 2024 25.27K $5.81M Add
Q2 2024 24.44K $7.79M Reduce
Q3 2024 38.91K $13.94M Add
Q4 2024 40.22K $14.19M Add
Q1 2025 121.97K $37.60M Add
Q2 2025 125.54K $36.07M Add
Q3 2025 146.99K $61.62M Add
Q4 2025 145.52K $70.91M Reduce
Q1 2026 104.67K $62.07M Reduce
Q2 2026 76.83K $41.63M Reduce
Q3 2026 72.71K $39.40M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About UTHR and 13F data

UTHR (UNITED THERAPEUTICS CORP DEL) is a Health Care company. 39 other funds we track also report a position in UTHR — the largest reported positions include Avoro Capital Advisors LLC (US$1.51B), Renaissance Technologies (US$908.2M), ASSETMARK, INC (US$325.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding UTHR

All UTHR fund holders →

FAQ

How long has SEIZERT CAPITAL PARTNERS, LLC held UTHR?

SEIZERT CAPITAL PARTNERS, LLC has disclosed UTHR holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is SEIZERT CAPITAL PARTNERS, LLC's current position in UTHR?

As of Q3 2026, SEIZERT CAPITAL PARTNERS, LLC holds 72.71K shares of UTHR (UNITED THERAPEUTICS CORP DEL), valued at $39.40M, representing 1.71% of its reported portfolio and ranking #31.

Has SEIZERT CAPITAL PARTNERS, LLC been buying or selling UTHR?

In the latest 13F filing (Q3 2026), SEIZERT CAPITAL PARTNERS, LLC reduced its position in UTHR. The position peaked in Q4 2025 at 145.52K shares.

Which other funds hold UTHR?

Other major institutional holders of UTHR include Avoro Capital Advisors LLC, Renaissance Technologies, ASSETMARK, INC, among 39 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.